Tender detail
Non-exclusive rebate agreement for medicines containing Dornase alfa
Summary
The tender concerns a non-exclusive rebate agreement for medicines containing the active substance Dornase alfa for the period 01/07/2026 to 30/06/2028. DAK-Gesundheit intends to conclude the agreement with as many interested pharmaceutical companies as possible, and the exact list of medicines must be specified in the contract annex. The machine-readable notice did not include precise compliance or qualification requirements; these must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.